Phase 3 Study of M923 and Humira® in Subjects With Chronic Plaque-type Psoriasis
Clinical trial NCT02581345 · COMPLETED
Trial details
- NCT number
- NCT02581345
- Sponsor
- Momenta Pharmaceuticals, Inc.
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2015-09-01
- Primary completion
- 2017-04-04
- Enrollment
- 572
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.